Dr. Samuel K. Mcgowan
Overview
Dr. Samuel McGowan is a pulmonary and critical care specialist who cares for patients with a variety of lung conditions. He provides treatment in the intensive care unit (ICU) as well as other settings. He is medical director of the UCSF OPTIMAL Clinic, which serves patients recovering from critical illness or experiencing persistent COVID-19-related pulmonary symptoms. McGowan's research focuses on improving the quality of ICU care and examining how critical illness affects ICU survivorship. He believes that treating patients as individuals is the foundation of providing holistic, compassionate care for all. McGowan earned his medical degree at Rush Medical College, where he also completed a residency in internal medicine and served as chief resident. He completed a fellowship in pulmonary and critical care medicine at UCSF. When not working, McGowan enjoys spending time with his family, reading, playing basketball and being outdoors.
His clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
400 Parnassus Ave., Sixth Floor, Room A6114, San Francisco, CA 94143
520 Illinois St., San Francisco, CA 94158
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Interstitial Lung Disease (ILD) Program
Dr. Paul J. Wolters specializes in the diagnosis and care of patients with interstitial lung disease, a category of disorders in which scarring of lung tissue affects breathing. Wolters is actively involved in research that aims to better understand the development of idiopathic pulmonary fibrosis, a type of interstitial lung disease. He is director of biological research for the UCSF Interstitial Lung Disease Program. Wolters received his medical degree from the University of Minnesota. He completed a residency in internal medicine at the University of Colorado, and a fellowship in pulmonary and critical care medicine at UCSF. He joined UCSF's division of pulmonary and critical care medicine in 1999. Dr. Wolters is highly rated in 12 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Pulmonary Fibrosis, and Lung Transplant.
University Of California San Francisco
Christopher Ryerson is a Pulmonary Medicine provider in San Francisco, California. Dr. Ryerson is highly rated in 16 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Lung Transplant, and Endoscopy.
Interstitial Lung Disease (ILD) Program
Dr. Laura Koth is a pulmonologist and an expert in interstitial lung disease. She is co-director of UCSF's interstitial lung disease center of excellence. Koth's research activities focus on the mechanisms of lung inflammation and macrophage activation. Macrophages are a type of white blood cell with important roles in immune response. Koth earned her medical degree from Harvard Medical School. She completed residency training in internal medicine at Massachusetts General Hospital, followed by a fellowship in pulmonary and critical care medicine UCSF. She joined the UCSF faculty in 2003. Dr. Koth is highly rated in 12 conditions, according to our data. Her top areas of expertise are Sarcoidosis, Hypersensitivity Pneumonitis, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, and Lung Transplant.
Frequently Asked Questions about Dr. Samuel K. Mcgowan
How do I make an appointment with Dr. Samuel K. Mcgowan?
You can book an appointment with Dr. Samuel K. Mcgowan by calling their office at 415-353-2961. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Does Dr. Samuel K. Mcgowan accept my insurance?
Dr. Samuel K. Mcgowan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 415-353-2961 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
We do not have enough information to identify the Areas of Expertise for this provider.